Wealthtrust Axiom LLC’s Eli Lilly & Co Position
Does Wealthtrust Axiom LLC own Eli Lilly & Co (LLY)? Yes — 8.8K shares worth $8M (+1.99% of its 13F portfolio) as of Q1 2026, down from 9.0K shares the prior filed quarter.
Position Value
$8M
Q1 2026
Shares
8.8K
% of Portfolio
+1.99%
Quarters Held
30
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 8.8K | $8M | +1.99% |
| Q4 2025 | 9.0K | $10M | +2.50% |
| Q3 2025 | 9.9K | $8M | +2.03% |
| Q2 2025 | 9.8K | $8M | +2.25% |
| Q1 2025 | 10.2K | $8M | +2.57% |
| Q4 2024 | 10.5K | $8M | +2.43% |
| Q3 2024 | 10.4K | $9M | +2.73% |
| Q2 2024 | 10.9K | $10M | +3.27% |
| Q1 2024 | 11.1K | $9M | +2.77% |
| Q4 2023 | 11.8K | $7M | +2.30% |
| Q3 2023 | 12.1K | $7M | +2.35% |
| Q2 2023 | 12.4K | $6M | +1.94% |
| Q1 2023 | 12.4K | $4M | +1.46% |
| Q4 2022 | 11.9K | $4M | +1.52% |
| Q3 2022 | 12.0K | $4M | +1.48% |
| Q2 2022 | 12.0K | $4M | +1.39% |
| Q1 2022 | 12.0K | $3M | +1.07% |
| Q4 2021 | 12.1K | $3M | +1.07% |
| Q3 2021 | 12.1K | $3M | +0.95% |
| Q2 2021 | 12.2K | $3M | +0.90% |
| Q1 2021 | 11.2K | $2M | +0.71% |
| Q4 2020 | 11.2K | $2M | +0.69% |
| Q3 2020 | 11.3K | $2M | +0.72% |
| Q2 2020 | 11.3K | $2M | +0.82% |
| Q1 2020 | 17.4K | $2M | +1.18% |
| Q4 2019 | 21.5K | $3M | +0.94% |
| Q3 2019 | 22.6K | $3M | +0.89% |
| Q2 2019 | 23.6K | $3M | +0.91% |
| Q1 2019 | 23.7K | $3M | +1.09% |
| Q4 2018 | 26.7K | $3M | +1.27% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Wealthtrust Axiom LLC’s full portfolio or all institutional holders of LLY.